Financials

  • Market Capitalization 220.29 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.53
市销率
8.08

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3451
KROS
Keros Therapeutics, Inc. - common stock
11.61 USD-2.85%+0.43%+4.59%-23.11%230.19 M USD
3469
PLX
Protalix BioTherapeutics, Inc. Common Stock
2.78 USD+0.72%+3.73%+6.11%-4.79%223.99 M USD
3479
STRO
Sutro Biopharma, Inc. - Common Stock
13.28 USD-6.94%-12.29%-22.29%-23.63%220.20 M USD
3494
TRDA
Entrada Therapeutics, Inc. - Common Stock
5.50 USD-3.00%-0.36%-19.12%-21.09%214.15 M USD